|
1
|
Kuo CF, Luo SF, Yu KH, Chou IJ, Tseng WY,
Chang HC, Fang YF, Chiou MJ and See LC: Cancer risk among patients
with systemic sclerosis: a nationwide population study in Taiwan.
Scand J Rheumatol. 41:44–49. 2012. View Article : Google Scholar
|
|
2
|
Kang KY, Yim HW, Kim IJ, Yoon JU, Ju JH,
Kim HY and Park SH: Incidence of cancer among patients with
systemic sclerosis in Korea: results from a single centre. Scand J
Rheumatol. 38:299–303. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siau K, Laversuch Cj, Creamer P and
O’Rourke KP: Malignancy in scleroderma patients from south west
England: a population-based cohort study. Rheumatol Int.
31:641–645. 2011. View Article : Google Scholar
|
|
4
|
Szekanecs E, Szamosi S, Horvath A, Nemeth
A, Juhasz B, Szanto J, Szücs G and Szekanecz Z: Malignancies
associated with systemic sclerosis. Autoimmun Rev. 11:852–855.
2012. View Article : Google Scholar
|
|
5
|
Derk CT, Rasheed M, Artlett CM and Jimenez
SA: A cohort study of cancer incidence in systemic sclerosis. J
Rheumatol. 33:1113–1116. 2006.PubMed/NCBI
|
|
6
|
Derk CT, Rasheed M, Spiegel JR and Jimenez
SA: Increased incidence of carcinoma of the tongue in patients with
systemic sclerosis. J Rheumatol. 32:637–641. 2005.PubMed/NCBI
|
|
7
|
Sobin LH, Gospodarowicz MK and Wittekind
Ch; International Union Against Cancer (UICC). TNM Classification
of Malignant Tumours. 7th edition. Wiley-Blackwell; New York, NY:
2009
|
|
8
|
Clements PJ and Furst DE: Systemic
Sclerosis. 1st edition. Williams & Wilkins; Baltimore, MD:
1996
|
|
9
|
Kumar P, Galarraga B and Belch JJF:
Connective tissues disorders. Rheumatology. Hochberg MC, Silman AJ,
Smolen JS, Weinblatt ME and Weisman MH: 5th edition. Mosby
Elsevier; Philadelphia, PA: pp. 1361–1437. 2011
|
|
10
|
Wigley FM: Systemic sclerosis
(scleroderma) is unique among our rheumatic diseases. Preface.
Rheum Dis Clin North Am. 34:xi–xiiii. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Štork J: Sklerodermie. 1st edition. Galén;
Prague: 1996
|
|
12
|
LeRoy EC, Black CM, Fleischmajer R, et al:
Scleroderma (systemic sclerosis): clasification, subsets and
pathogenesis. J Rheumatol. 15:202–205. 1988.PubMed/NCBI
|
|
13
|
Orphanos G, Ardavanis A, Charalambous P,
Stavrakakis J and Rigatos G: Systemic sclerosis associated with
rectal cancer. Case report and a brief review of the literature. In
vivo. 22:825–830. 2008.
|
|
14
|
Szabolcsi O, Nagy-Toldi A, Zeher M and
Vegh J: Systemic sclerosis in a patient suffering from breast
cancer. Magy Onkol. 56:50–54. 2012.PubMed/NCBI
|
|
15
|
Marasini B, Conciato L, Belloli L and
Massarotti M: Systemic sclerosis and cancer. Int J Immunopathol
Pharmacol. 22:573–578. 2009.PubMed/NCBI
|
|
16
|
Dragun AE, Harper JL, Olyejar SE,
Zunzunegui RG and Wazer DE: The use of adjutant high-dose-rate
breast brychytherapy in patients with collagen vascular dinase: a
collaborative experience. Brachytherapy. 10:121–127. 2011.
View Article : Google Scholar
|
|
17
|
Kounalakis N, Pezner R, Staud CL and
Kruper L: Partial breast irradiation in a patient with bilateral
breast cancers and CREST syndrome. Brachytherapy. 10:486–490. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lowell D, Tatter S, Bourland JD, deGuzman
AF, Ekstrand KF, Ellis TL, Lovato JF, McMullen K, Munley MJ, Shaw
EG, et al: Toxicity of gamma knife radiosurgery in the treatment of
intracranial tumors in patients with collagen vascular diseases or
multiple sclerosis. Int J Radiat Oncol Biol Phys. 81:e519–e524.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin A, Abu-Isa E, Griffith KA and
Ben-Josef E: Toxicity of radiotherapy in patients with collagen
vascular disease. Cancer. 113:648–653. 2008. View Article : Google Scholar : PubMed/NCBI
|
